AstraZeneca's (AZN) "Top Pick" Rating Reaffirmed at Barclays

Marco Green
April 3, 2018

After having $1.30 EPS previously, AstraZeneca PLC's analysts see -66.15% EPS growth.

The stock increased 2.33% or $0.35 during the last trading session, reaching $15.4. About 90,521 shares traded.

Archford Capital Strategies Llc decreased its stake in Astrazeneca Plc Sponsored Adr (AZN) by 64.15% based on its latest 2017Q4 regulatory filing with the SEC. Commerce Bank now owns 11,548 shares of the company's stock valued at $400,000 after buying an additional 1,480 shares in the last quarter. Archford Capital Strategies Llc sold 47,982 shares as the company's stock rose 3.15% while stock markets declined. R-M Sincerbeaux Capital Management who had been investing in General Electric Co for a number of months, seems to be less bullish one the $117.05 billion market cap company. The stock decreased 1.46% or $0.04 during the last trading session, reaching $2.7. About 2.40 million shares traded.

Analysts expect AstraZeneca PLC (NYSE:AZN) to report $0.44 EPS on April, 26.They anticipate $0.55 EPS change or 55.56% from last quarter's $0.99 EPS. It has underperformed by 2.52% the S&P500. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 65% are positive. The rating was upgraded by J.P. Morgan to "Buy" on Friday, December 29. The company was upgraded on Wednesday, September 2 by HSBC. Citigroup maintained the stock with "Buy" rating in Wednesday, October 18 report. The firm has "Buy" rating by Citigroup given on Wednesday, October 18. JPMorgan Chase & Co. set a GBX 5,500 ($75.99) price objective on AstraZeneca and gave the stock a buy rating in a report on Thursday, January 4th. ValuEngine raised shares of AstraZeneca from a "buy" rating to a "strong-buy" rating in a research report on Saturday, February 3rd. The firm has "Outperform" rating given on Friday, December 16 by Bernstein. The company was initiated on Friday, September 23 by Piperjaffray. AstraZeneca PLC (NYSE:AZN) has risen 9.03% since April 2, 2017 and is uptrending. Delpha Capital Management LLC acquired a new stake in shares of AstraZeneca in the fourth quarter worth $152,000. It also reduced Improvenet Inc (NYSE:IMPV) stake by 34,002 shares and now owns 81,300 shares.

Since October 23, 2017, it had 0 insider buys, and 3 sales for $26.33 million activity. (NYSE:WBC) was sold by Bardot Nicolas. (NYSE:WBC) to report earnings on April, 20. During the same period in the previous year, the firm posted $1.21 earnings per share. GE's profit will be $1.04B for 28.08 P/E if the $0.12 EPS becomes a reality. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.44 by $0.86.

Investors sentiment increased to 1.28 in 2017 Q4. Its down 0.19, from 0.69 in 2017Q3. It is negative, as 30 investors sold WBC shares while 102 reduced holdings. 151 funds opened positions while 383 raised stakes. Tci Wealth Advsr Inc reported 74,401 shares. 17 are owned by Howe & Rusling Inc. (NYSE:WBC) or 8,944 shares. (NYSE:WBC). 2,650 were reported by Sg Americas Secs Ltd Limited Liability Company. State Board Of Administration Of Florida Retirement Systems invested in 0.01% or 168,062 shares. (NYSE:WBC) for 163,406 shares. Private Advisor Group Inc Ltd Liability reported 0.01% in Fulton Financial Corporation (NASDAQ:FULT). (NYSE:WBC) for 15,906 shares. Chemung Canal Trust reported 129,873 shares stake. The company's revenue for the quarter was up 3.4% on a year-over-year basis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article